Table 2.
Vital Organ Support | Patients Receiving Vital Organ Support | Women Receiving Vital Organ Support |
Men Receiving Vital Organ Support |
---|---|---|---|
Invasive ventilation (n = 697,785) | 225,306 (32.2%) | 78,510 (25.7%) | 146,796 (37.3%) |
Noninvasive ventilation (n = 583,077) | 62,849 (10.8%) | 27,221 (10.6%) | 35,628 (10.9%) |
Vasoactive medication (n = 587,709) | 214,398 (36.3%) | 81,940 (31.7%) | 132,458 (39.8%) |
Renal replacement therapy (n = 575,376) | 23,399 (4.1%) | 8,688 (3.4%) | 14,711 (4.6%) |
Extracorporeal membrane oxygenation (n = 574,751) | 1,580 (0.3%) | 549 (0.2%) | 1,031 (0.3%) |
Any vital organ support (n = 609,329) | 339,722 (55.1%) | 131,493 (49.4%) | 208,229 (59.5%) |
APACHE = Acute Physiology and Chronic Health Evaluation, n = patients with complete data for each organ support.
Data are presented as number and percentage of patients, mean with sd, absolute difference in means (99% CI), or odds ratios (99% CI) (see Table E2, http://links.lww.com/CCM/H424, for further details).